Concepedia

Harsh P. Nijhawan

HP

Statistics

Publications

7

Citations

128

H-Index

7

Active since

2022

Affiliations

Narsee Monjee Institute of Management Studies(Current)

Harsh P. Nijhawan is an author at Narsee Monjee Institute of Management Studies specializing in nanomedicine, pharmacology, and breast cancer.

ORCID

Top concepts

Publications per year

2022–2025

7

Publications

7

Sorafenib tosylate novel drug delivery systems: Implications of nanotechnology in both approved and unapproved indications

Hrushikesh C. Raut, Chetana Jadhav, Karishma Shetty et al. · OpenNano · 2022 · 32 citations · Full text

PEGylated Erlotinib HCl Injectable Nanoformulation for Improved Bioavailability

Hardik Bhargave, Harsh P. Nijhawan, Khushwant S. Yadav · AAPS PharmSciTech · 2023 · 22 citations

, , +4

PEGylated pH-Responsive Liposomes for Enhancing the Intracellular Uptake and Cytotoxicity of Paclitaxel in MCF-7 Breast Cancer Cells

Harsh P. Nijhawan, Pooja Shyamsundar, Bala Prabhakar et al. · AAPS PharmSciTech · 2024 · 21 citations

, , +11

Central composite design augmented quality-by-design-based systematic formulation of erlotinib hydrochloride-loaded chitosan-poly (lactic-co-glycolic acid) nanoparticles

Harsh P. Nijhawan, Bala Prabhakar, Khushwant S. Yadav · Therapeutic Delivery · 2024 · 16 citations · Full text

Inhalable spray-dried polycaprolactone-based microparticles of Sorafenib Tosylate with promising efficacy on A549 cells

Khushwant S. Yadav, Hrushikesh C. Raut, Harsh P. Nijhawan · Pharmaceutical Development and Technology · 2023 · 15 citations

Rows per page

1–5 of 7